229 related articles for article (PubMed ID: 11365885)
1. Don't mix Sustiva with Fortovase.
Posit Aware; 1998; 9(5):17. PubMed ID: 11365885
[TBL] [Abstract][Full Text] [Related]
2. Efavirenz and Fortovase.
Baker R
BETA; 1998 Jul; ():9. PubMed ID: 11365572
[TBL] [Abstract][Full Text] [Related]
3. Update on antivirals.
Proj Inf Perspect; 1997 Nov; (23):8-11. PubMed ID: 11365381
[TBL] [Abstract][Full Text] [Related]
4. No more twice-a-day Crixivan.
Vazquez E
Posit Aware; 1998; 9(6):17. PubMed ID: 11366469
[TBL] [Abstract][Full Text] [Related]
5. [HIV infection: DuPont Pharma presents the results of its antiretroviral agent].
Allerg Immunol (Paris); 1998 Apr; 30(4):123-4. PubMed ID: 9631694
[No Abstract] [Full Text] [Related]
6. Methadone and anti-HIV drugs.
Fornataro K
Body Posit; 1999 May; 12(5):13. PubMed ID: 11366305
[TBL] [Abstract][Full Text] [Related]
7. Anti-HIV agents. Saquinavir--switching from Fortovase to Invirase.
TreatmentUpdate; 2004; 16(3):8-9. PubMed ID: 17219608
[No Abstract] [Full Text] [Related]
8. What's new and what's next.
Fakuda D
Posit Dir News; 1998 Jan; 10(1):25-9. PubMed ID: 11365053
[TBL] [Abstract][Full Text] [Related]
9. Dupont data supports earlier findings.
Slovick J
Posit Living; 1999 Nov; 8(10):45. PubMed ID: 11367331
[TBL] [Abstract][Full Text] [Related]
10. New study shows efavirenz effective with d4T and 3TC.
AIDS Alert; 1999 May; 14(5):60. PubMed ID: 11366404
[TBL] [Abstract][Full Text] [Related]
11. Low increase in serum lipids in patients receiving a combination of ritonavir, saquinavir and efavirenz.
Piketty C; Peytavin G; Trylezinski A; Gonzalez-Canali G; Castiel P; Weiss L; Kazatchkine MD
HIV Med; 2002 Oct; 3(4):287-9. PubMed ID: 12444948
[No Abstract] [Full Text] [Related]
12. Protease inhibitor combos.
Newsline People AIDS Coalit N Y; 1998 Feb; ():36-7. PubMed ID: 11367448
[TBL] [Abstract][Full Text] [Related]
13. Sustiva added to three-drug combination.
AIDS Patient Care STDS; 1998 Oct; 12(10):803. PubMed ID: 11362030
[No Abstract] [Full Text] [Related]
14. Switching from protease inhibitors to the non-nuke efavirenz.
TreatmentUpdate; 2001; 12(12):3. PubMed ID: 11570089
[No Abstract] [Full Text] [Related]
15. Protease inhibitors at a glance...
Notes Undergr; 1998-1999 Winter; (No 38):suppl 1-4. PubMed ID: 11366198
[TBL] [Abstract][Full Text] [Related]
16. Dupont pharmaceuticals study 006 for Sustiva.
Bartlett JG
Hopkins HIV Rep; 1998 Sep; 10(5):1. PubMed ID: 11365772
[TBL] [Abstract][Full Text] [Related]
17. Efavirenz (SUSTIVA, formerly DMP-266) 48-week data announced.
AIDS Treat News; 1997 Sep; (No 279):2-3. PubMed ID: 11364690
[TBL] [Abstract][Full Text] [Related]
18. Efavirenz (Sustiva) on fast-track for FDA accelerated approval. Food and Drug Administration.
Baker R
BETA; 1998 Jul; ():9. PubMed ID: 11365571
[TBL] [Abstract][Full Text] [Related]
19. What they say about protease inhibitors.
Posit Aware; 1999; 10(1):38-43. PubMed ID: 11366522
[TBL] [Abstract][Full Text] [Related]
20. [HIV infections: mortality reduced only in developed countries].
Wehr A
Dtsch Med Wochenschr; 1999 May; 124(18):A8-9. PubMed ID: 10356577
[No Abstract] [Full Text] [Related]
[Next] [New Search]
